Accuray Inc (ARAY.O)

ARAY.O on Nasdaq

31 Jul 2015
Change (% chg)

$-0.09 (-1.39%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ARAY.O


Accuray Incorporated is a radiation oncology company. The Company develops, manufactures, sells and supports precise, innovative treatment solutions. The Company’s technologies are designed to deliver advanced radiation therapy, including radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy,... (more)


Beta: 1.25
Market Cap(Mil.): $503.94
Shares Outstanding(Mil.): 78.99
Dividend: --
Yield (%): --


  ARAY.O Industry Sector
P/E (TTM): -- 16.76 40.14
EPS (TTM): -0.57 -- --
ROI: -14.55 2.59 15.75
ROE: -51.56 2.82 16.79
Search Stocks

BRIEF-Raysearch says inks long-term sales agreement with Accuray

* Says Accuray and Raysearch announce long-term collaboration agreement regarding the Raycare oncology information system

13 Jul 2015

BRIEF-Scandidos sells Delta4 Phantom to Accuray

* Says has been selected by Accuray as supplier of measurement system Delta4 Phantom Source text: Further company coverage: (Gdynia Newsroom)

31 Mar 2015


Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
Provider : Reuters Investment Profile
Provider : Thomson Reuters Stock Report
Provider : New Constructs, LLC
Provider : ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks